Products

Sandoo magnum est Ketorolac Trometamolum, Hydrochloridum Olopatadinum, Vancomycin hydrochloridum artifices et praebitores in Sinis. Nostra officina in API, anti-cancro, antivirali medicamento media, subtilia chemicis, cibariis additivis export et plus quam X annos importat, positi sunt, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniae Regnum. Gallia, etc., et paulatim plus XX regionibus circum orbem terrarum tegunt.
View as  
 
2-Amino-5-methylpyridine

2-Amino-5-methylpyridine

Product Name:2-Amino-5-methylpyridine
Formulae hypotheticae: C6H8N2
Molecular pondus:108.14
CAS Registry Number: 1603-41-4

Lege plusMitte Inquisitionem
2-Amino-3-(trifluoromethyl)pyridine

2-Amino-3-(trifluoromethyl)pyridine

Product Name:2-Amino-3-(trifluoromethyl)pyridine
Formulae hypotheticae: C6H5F3N2
Molecular pondus:162.11
CAS Subcriptio Number:183610-70-0

Lege plusMitte Inquisitionem
2-Hydroxy-3-trifluoromethylpyridine

2-Hydroxy-3-trifluoromethylpyridine

Product Name:2-Hydroxy-3-trifluoromethylpyridine
Formulae hypotheticae: C6H4F3NO
Molecular pondus:163.1
CAS Subcriptio Number:22245-83-6

Lege plusMitte Inquisitionem
2-Chloro-3-(trifluoromethyl) pyridine

2-Chloro-3-(trifluoromethyl) pyridine

Product Name:2-Chloro-3-(trifluoromethyl)pyridine
Formulae hypotheticae: C6H3ClF3N
Molecular pondus:181.54
CAS Registry Number: 65753-47-1

Lege plusMitte Inquisitionem
1-(3-Dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride

1-(3-Dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride

Product Name: 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
Formulae hypotheticae: C8H18ClN3
Molecular pondus:191.7
CAS Subcriptio Number:25952-53-8

Lege plusMitte Inquisitionem
(R) -Styrene oxydatum

(R) -Styrene oxydatum

Product Name:(R) -Styrene oxydatum
Formulae hypotheticae: C8H8O
Pondus hypotheticum: 120.15
CAS Subcriptio Number:20780-53-4

Lege plusMitte Inquisitionem
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept